Discover key insights from Vaxart's Q1 2025 earnings call, including progress on COVID-19 trials, norovirus pipeline updates, funding strategies, and ...

A Washington DC man was left excessively bleeding due to a rare side effect linked to his Covid vaccine booster.

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

Facebook posts make the claim, stating: "The Food and Drug Administration (FDA) has admitted that unvaccinated people are at ...

Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the ...

RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines against several influenza strains and severe acute respiratory syndrome coronavirus ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

I am a 77-year-old female in good health. I am up to date on all vaccines, but I would like to know why after each COVID shot ...

Among participants aged 65 and older, mRNA-1083 outperformed the high-dose flu vaccine for three flu strains: A/H1N1, A/H3N2, ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Central District Health (CDH) will continue to provide COVID-19 vaccines to residents in Ada, Boise, Elmore, and Valley ...